Clinical outcomes of tebentafusp in metastatic uveal melanoma: a systematic review and single-arm meta-analysis - Top-Institutions - MDSpire

Clinical outcomes of tebentafusp in metastatic uveal melanoma: a systematic review and single-arm meta-analysis

  • By

  • Han Cai

  • Zhilong Huang

  • Bing-Long Wang

  • Ming Wei

  • Miao Tian

  • Hongmei Zheng

  • June 17, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Melanoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Melanoma

  • #3

    Leiden University Medical Centre
    Leiden University Medical Centre

    Leiden, South Holland

    Key Differentiators

    • Oncology

Original Source(s)

Clinical outcomes of tebentafusp in metastatic uveal melanoma: a systematic review and single-arm meta-analysis

  • by Han Cai, Zhilong Huang, Bing-Long Wang, Ming Wei, Miao Tian, Hongmei Zheng

  • June 17, 2026

Related Content

Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics

Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report

Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma